sphingosine kinase 1/2
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor negative breast cancer via Src family kinase mediated, janus kinase 2 independent pathway
15
The roles of sphingosine kinase 1 and 2 in regulating the metabolome and survival of prostate cancer cells
18
Sphingosine kinase 1 and sphingosine 1 phosphate receptor 2 are vital to recovery from anaphylactic shock in mice
13
Crystal structure of sphingosine kinase 1 with PF-543
5
Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1
9
Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse
9
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
10
Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer
14
Sphingosine kinase 1 expression enhances colon tumor growth
8
Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma
13
An novel role of sphingosine kinase 1 (SPHK1) in the invasion and metastasis of esophageal carcinoma
15
Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodeling in a hypoxic model of pulmonary arterial hypertension
10
Sphingosine kinase 2 prevents the nuclear translocation of sphingosine 1-phosphate receptor-2 and tyrosine 416 phosphorylated c-Src and increases estrogen receptor negative MDA-MB-231 breast cancer cell growth : the role of sphingosine 1-phosphate receptor-4
51
Sphingosine 1-phosphate receptors and sphingosine kinase 1 : novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers
5
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells
13
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells
13
Sphingosine kinase 1 as an anticancer therapeutic target
7
Sphingosine kinase 2 in autoimmune/inflammatory disease and development of sphingosine kinase 2 inhibitors
24
Expressions of Sphingosine 1 phosphate (S1P) Receptors, Sphingosine Kinases in Malignant Bone and Soft Tissue Tumors, and The role of Sphingosine Kinase 1 in Growth of MFH Cell Lines
7
Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer’s disease brain
14